ロード中...
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
INTRODUCTION: Novel compounds with potential to attenuate or stop the progression of Alzheimer's disease (AD) from its presymptomatic stage to dementia are being tested in man. The study design commonly used is the long-term randomized, placebo-controlled trial (RPCT), meaning that many patient...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3226271/ https://ncbi.nlm.nih.gov/pubmed/21418632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt68 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|